Literature DB >> 21986871

Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Ming Li1, Tao Sun, Alexa Mead.   

Abstract

The present study was designed to assess the role of 5-HT(2A/2C) receptors in the acute and repeated effect of clozapine and olanzapine in a rat conditioned avoidance response model, a validated model of antipsychotic activity. Male Sprague-Dawley rats that were previously treated with either phencyclidine (0.5-2.0 mg/kg, sc), amphetamine (1.25-5.0 mg/kg, sc), or saline and tested in a prepulse inhibition of acoustic startle study were used. They were first trained to acquire avoidance response to a white noise (CS1) and a pure tone (CS2) that differed in their ability to predict the occurrence of footshock. Those who acquired avoidance response were administered with clozapine (10.0 mg/kg, sc) or olanzapine (1.0 mg/kg, sc) together with either saline or 1-2,5-dimethoxy-4-iodo-amphetamine (DOI, a selective 5-HT(2A/2C) agonist, 1.0 or 2.5 mg/kg, sc), and their conditioned avoidance responses were tested for four consecutive days. After two drug-free retraining days, the long-term repeated effect was assessed in a challenge test during which all rats were injected with a low dose of clozapine (5 mg/kg, sc) or olanzapine (0.5 mg/kg). Results show that pretreatment of DOI dose-dependently reversed the acute disruptive effect of clozapine on both CS1 and CS2 avoidance responses, whereas it had little effect in reversing the acute effect of olanzapine. On the challenge test, pretreatment of DOI did not alter the clozapine-induced tolerance or the olanzapine-induced sensitization effect. These results confirmed our previous findings and suggest that clozapine, but not olanzapine, acts on through 5-HT(2A/2C) receptors to achieve its acute avoidance disruptive effect and likely its therapeutic effects. The long-term clozapine tolerance and olanzapine sensitization effects appear to be mediated by non-5-HT(2A/2C) receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986871      PMCID: PMC3275656          DOI: 10.1007/s00702-011-0722-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  41 in total

1.  DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors.

Authors:  T.E. Sipes; M.A. Geyer
Journal:  Behav Pharmacol       Date:  1995-12       Impact factor: 2.293

2.  DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.

Authors:  J Ichikawa; J Dai; H Y Meltzer
Journal:  Brain Res       Date:  2001-07-13       Impact factor: 3.252

3.  Peter B. Dews and pharmacological studies on behavior.

Authors:  James E Barrett; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2008-06-10       Impact factor: 4.030

4.  Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: effects of drug administration regimen.

Authors:  Ming Li; Wei He; Jing Chen
Journal:  Pharmacol Biochem Behav       Date:  2011-05-10       Impact factor: 3.533

5.  Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Authors:  Chen Zhang; Yiru Fang; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2010-12-29       Impact factor: 3.533

6.  The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).

Authors:  M I Granoff; C R Ashby
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

7.  Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.

Authors:  J Arnt
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-10

8.  c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.

Authors:  C Zhao; M Li
Journal:  Neuroscience       Date:  2010-01-22       Impact factor: 3.590

9.  Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism.

Authors:  A Mead; M Li
Journal:  J Psychopharmacol       Date:  2009-03-27       Impact factor: 4.153

10.  Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.

Authors:  Christina Kurre Olsen; Lise Tøttrup Brennum; Mads Kreilgaard
Journal:  Eur J Pharmacol       Date:  2008-02-12       Impact factor: 4.432

View more
  19 in total

1.  Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.

Authors:  Shinnyi Chou; Sean Jones; Ming Li
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

2.  Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.

Authors:  Jun Gao; Rongyin Qin; Ming Li
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

3.  Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

4.  Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.

Authors:  Rongyin Qin; Yingzhu Chen; Ming Li
Journal:  Neuropharmacology       Date:  2013-08-14       Impact factor: 5.250

5.  Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

Authors:  Shinnyi Chou; Collin Davis; Sean Jones; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2014-11-26       Impact factor: 3.533

6.  Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.

Authors:  Qing Shu; Gang Hu; Ming Li
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

7.  Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.

Authors:  Chen Zhang; Ming Li
Journal:  Behav Pharmacol       Date:  2012-02       Impact factor: 2.293

8.  Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Behav Brain Res       Date:  2012-10-23       Impact factor: 3.332

9.  Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-08-31       Impact factor: 3.533

10.  Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

Authors:  Jun Gao; Ming Li
Journal:  Behav Brain Res       Date:  2013-10-05       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.